ACOG Committee Opinion Number 642, October 2015: Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy.

Ali M, Bahamondes L, Bent Landoulsi S. Extended Effectiveness of the Etonogestrel-Releasing Contraceptive Implant and 20 µg Levonorgestrel-Releasing Intrauterine System for 2 Years Beyond U.S. FDA Product Labeling. Glob Health Sci Pract. 2017 Dec28;5(4):534-539.

Amico JR, et al. Taking the provider “out of the loop:” patients’ and physicians’ perspectives about IUD self-removal. Contraception. 2018 Oct;98(4):288-291.

ASEC Factsheet:  Providing Ongoing Hormonal Contraception after Use of Emergency Contraceptive Pills, Sep 2016.

Bahamondes MV, Espejo-Arce X, Bahamondes L. Effect of vaginal administration of misoprostol before intrauterine contraceptive insertion following previous insertion failure: a double blind RCT. Hum Reprod. 2015 Aug;30(8):1861-6.

Bellanca HK, Hunter MS. ONE KEY QUESTION®: Preventive reproductive health is part of high quality primary care. Contraception. 2013 Jul;88(1):3-6.

Becker, Tsui. Reproductive health service preferences and perceptions of quality among low-Income women. Perspectives on Sexual and Reproductive Health, 2008, 40(4)

Birgisson NE et al. Preventing Unintended Pregnancy: The Contraceptive CHOICE Project in Review. J Womens Health (Larchmt). 2015;24(5):349.

Bonnington A, Dianat S, Kerns J, Hawkins M, De Haan G, Obedin-Maliver J. Society of Family Planning clinical recommendations: Contraceptive counseling for transgender and gender diverse people who were assigned female sex at birth. Contraception. April 2020.

Boudreau D & Mukerjee R. Contraception Care for Transmasculine individuals on testosterone therapy. Journal of Midwifery & Women’s Health. July/August 2019. 64(4): 395-402.

Brandi K, Woodhams E, White KO, Mehta PK. An exploration of perceived contraceptive coercion at the time of abortion. Contraception. 2018;97(4):329334.

Centers for Disease Control. Providing Quality Family Planning Services: Recommendations of CDC and the U.S. Office of Population Affairs April 25, 2014 / 63(RR04); 1-29.

Centers for Disease Control. United States Selected Practice Recommendations for Contraceptive Use, 2016. MMWR, 2016

Centers for Disease Control. United States Medical Eligibility Criteria for Contraceptive Use, 2016. MMWR Early Release, 2016

Cleland K, et al.  The efficacy of intrauterine devices for emergency contraception: a systematic review of 35 years of experience. Hum Reprod. 2012 Jul;27(7):1994-2000.

Davies A, Fleming C. Do intrauterine device/intrauterine system users check their threads? J Fam Plann Reprod Health Care. 2014 Apr;40(2):122-5.

Dehlendorf C, et al. Contraceptive counseling: best practices to ensure quality communication and enable effective contraceptive use. Clin Obstet Gynecol. 2014 Dec;57(4):659-73.

Dehlendorf C, et al. Association of the quality of interpersonal care during family planning counseling with contraceptive use. Am J Obstet Gynecol. 2016 Jan 28.

Dehlendorf C, et al, D. Development of a patient-reported measure of the interpersonal quality of family planning care. Contraception. 2018 Jan;97(1):34-40.

Diedrich JT, Zhao Q, Madden T, Secura GM, Peipert JF. Three-year continuation of reversible contraception. Am J Obstet Gynecol. 2015 Nov;213(5):662.e1-8.

Edelman A. Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception. Cochrane Syst Rev. 2014 Jul 29;2014(7):CD004695.

Foster DG, et al. Number of oral contraceptive pill packages dispensed, method continuation, and costs. Obstet Gynecol. 2006 Nov;108(5):1107-14.

Foster DG, et al. Interest in and experience with IUD self-removal. Contraception. 2014 Jul;90(1):54-9.

Glasier A, et al.  Can we identify women at risk of pregnancy despite using emergency contraception? Contraception 2011; 84:363–367.

Grossman D.  Routine follow-up visits after first trimester induced abortion.  Obstet Gynecol.  2004 April:  103(4): 738-745.

Guttmacher Institute. Reasons for Unmet Need for Contraception in Developing Countries. June 2016.

Hubacher D, et al. Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women. New England Journal of Medicine. 2001;345,561-7.

Krempasky C, Harris M, Abern L, Grimstad F. Contraception across the transmasculine spectrum. American Journal of Obstetrics and Gynecology. 2020 Feb;222(2):134-143.

London A, Jensen JT. Rationale for eliminating the hormone-free interval in modern oral contraceptives. Int J Gynaecol Obstet. 2016 Mar 20. pii: S0020-7292(16)30040-6.

Lopez LM, et al. Hormonal contraceptives for contraception in overweight or obese women. Cochrane Database of Systematic Reviews 2016, Issue 8. Art. No.: CD008452.

Matulich M, et al. Understanding women’s desires for contraceptive counseling at the time of first-trimester surgical abortion.Contraception. 2014 Jan;89(1):36-41.

Mody SK, et al. Paracervical Block for Intrauterine Device Placement Among Nulliparous Women: A Randomized Controlled Trial. Obstet Gynecol. 2018;132(3):575582.

Raifman S, et al. Effect of Knowledge of Self-removability of Intrauterine Contraceptives on Uptake, Continuation, and Satisfaction. Womens Health Issues. 2018 Jan – Feb;28(1):68-74.

Raymond EG, Weaver MA, Louie KS, et al. Effects of Depot Medroxyprogesterone Acetate Injection Timing on Medical Abortion Efficacy and Repeat Pregnancy: A Randomized Controlled Trial. Obstet Gynecol. 2016;128(4):739745.

Raymond EG, et al. Effect of Immediate Compared With Delayed Insertion of Etonogestrel Implants on Medical Abortion Efficacy and Repeat Pregnancy: A Randomized Controlled Trial. Obstet Gynecol. 2016;127(2):306312.

Shen J, Che Y, Showell E, Chen K, Cheng L. Interventions for emergency contraception.Cochrane Database Syst Rev. 2017 Aug 2;8(8):CD001324.

Sufrin CB, Averbach SH. Testing for sexually transmitted infections at intrauterine device insertion: an evidence-based approach. Clin Obstet Gynecol. 2014 Dec;57(4):682-93.

Ti AJ, et al. Effectiveness and safety of extending intrauterine device duration: a systematic review. Am J Obstet Gynecol. 2020 Jan 15.

Turok DK, et al. Emergency contraception with a copper IUD or oral levonorgestrel: an observational study of 1-year pregnancy rates. Contraception 2014; 89(3): 222-8.

Winner B, Peipert JF, Zhao Q, Buckel C, Madden T, Allsworth JE, Secura GM. Effectiveness of long-acting reversible contraception. N Engl J Med. 2012 May24;366(21):1998-2007.

Wu S, et al. Copper T380A intrauterine device for emergency contraception: a prospective, multicentre, cohort clinical trial. BJOG 2010;117:1205–1210.

Yee & Simon. Perceptions of Coercion, Discrimination, and other Negative Experiences in Post-Partum Contraceptive Counseling for Low-Income Minority Women. Journal of Health Care for the Poor and Underserved. Volume 22 Number 4. November 2011.


EARLY ABORTION TRAINING CURRICULUM Copyright © 2020 by UCSF Bixby Center for Global Reproductive Health. All Rights Reserved.